New MS injection trial aims to halt brain damage
NCT ID NCT05265728
Summary
This study tested a version of an existing MS drug, natalizumab, given as a shot under the skin every four weeks. It aimed to see if this new method of delivery could effectively reduce new brain lesions and relapses in Japanese adults with relapsing-remitting MS. The trial also monitored the treatment's safety and how the body processes the drug.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS, RELAPSING-REMITTING are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Chiba University Hospital
Chiba, 260-8677, Japan
-
Juntendo University Hospital
Bunkyō City, 113-8431, Japan
-
Kansai Medical University Medical Center
Moriguchi-shi, 570-8507, Japan
-
National Center of Neurology and Psychiatry
Kodaira-shi, 187-8551, Japan
-
National Hospital Organization Hokkaido Medical Center
Sapporo, 063-0005, Japan
-
Osaka University Hospital
Suita-shi, 565-0871, Japan
-
St.Marianna University Hospital
Kawasaki-shi, 216-8511, Japan
-
The Kitasato Institute Kitasato University Hospital
Sagamihara-shi, 252-0375, Japan
-
Tohoku Medical and Pharmaceutical University Hospital
Sendai, 983-8512, Japan
-
Tokyo Metropolitan Hospital Organization Tokyo Metropolitan Ebara Hospital
Ōta-ku, 145-0065, Japan
-
Tokyo Women's Medical University Yachiyo Medical Center
Yachiyo-shi, 276-8524, Japan
-
University of Tsukuba Hospital
Tsukuba, 305-8576, Japan
Conditions
Explore the condition pages connected to this study.